Summit Therapeutics plc Aktie
Finanztrends
Deine Einschätzung
Was spricht für und gegen Summit Therapeutics plc in den nächsten Jahren?
Pro
?
M************
?
A****************
?
U****************
Kontra
?
L*********** I********** f** d** n******* J****
?
W******* i* V********
?
M****
Sag uns deine Meinung, um die 'Wisdom of the Crowds' zu nutzen
Rendite von Summit Therapeutics plc im Vergleich
| Wertpapier | Ver.(%) | 1W | 1M | 1J | YTD | 3J | 5J |
|---|---|---|---|---|---|---|---|
| Summit Therapeutics plc | - | - | - | - | - | - | - |
| Proteome Sciences | 53,57 % | 2,38 % | 330,00 % | 7,50 % | -25,86 % | -34,85 % | -27,12 % |
| Oxford BioMedica PLC | - | 3,60 % | 5,11 % | 41,18 % | 41,18 % | 72,25 % | -22,95 % |
| Sareum Holdings plc | - | 0,00 % | -6,38 % | -56,29 % | -56,29 % | -84,56 % | - |
Kommentare
News
2 Stocks Up Over 600% in the Past 3 Years With More Room to Run
Those who had the foresight to invest in Summit Therapeutics (NASDAQ: SMMT) and Madrigal Pharmaceuticals (NASDAQ: MDGL) three years ago are sitting pretty right now. Both companies have soared over
Why a $27 Million Buy Signals New Confidence in Weatherford Stock
Summit Street Capital Management established a new position in Weatherford International (NASDAQ:WFRD), adding 398,661 shares valued at an estimated $27.3 million during the third quarter, according
Signet Jewelers Gains New $25 Million Institutional Backer — Is the Stock a Buy?
On November 14, New York City-based Summit Street Capital Management disclosed a new position in Signet Jewelers (NYSE:SIG), acquiring 264,054 shares valued at $25.3 million, according to its latest